Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
93.86
+1.06 (1.14%)
At close: Apr 28, 2026, 4:00 PM EDT
93.86
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:06 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 115,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 0.88% compared to the previous year.
Employees
115,000
Change (1Y)
1,000
Growth (1Y)
0.88%
Revenue / Employee
$392,470
Profits / Employee
$54,365
Market Cap
163.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 115,000 | 1,000 | 0.88% |
| Dec 31, 2024 | 114,000 | 0 | - |
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
| Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
| Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
| Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
| Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
| Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
| Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
| Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
| Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
| Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
| Dec 31, 2012 | 91,000 | 0 | - |
| Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
| Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
| Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
| Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
| Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
| Dec 31, 2005 | 59,735 | -865 | -1.43% |
| Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
| Dec 31, 2003 | 72,200 | 381 | 0.53% |
| Dec 31, 2002 | 71,819 | 393 | 0.55% |
| Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
| Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
| Dec 31, 1999 | 57,100 | 864 | 1.54% |
| Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
| Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
| Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
| Dec 31, 1995 | 50,241 | 777 | 1.57% |
| Dec 31, 1994 | 49,464 | -195 | -0.39% |
| Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Medtronic | 95,000 |
| Koninklijke Philips | 65,340 |
| Boston Scientific | 59,000 |
| Stryker | 56,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
ABT News
- 7 hours ago - Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform - PRNewsWire
- 3 days ago - Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 - PRNewsWire
- 11 days ago - New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test - PRNewsWire
- 11 days ago - Abbott Laboratories Analysts Slash Their Forecasts After Q1 Earnings - Benzinga
- 12 days ago - Abbott Labs Annual Guidance Cut Overshadows Earnings Beat, Stock Cracks - Benzinga
- 12 days ago - Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales - WSJ
- 12 days ago - Abbott Laboratories Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting. - Barrons